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Abstract
Background: The vertebrate pancreas contains islet, acinar and ductal cells. These cells derive from a transient
pool of multipotent pancreatic progenitors during embryonic development. Insight into the genetic determinants
regulating pancreatic organogenesis will help the development of cell-based therapies for the treatment of
diabetes mellitus. Suppressor enhancer lin12/Notch 1 like (Sel1l) encodes a cytoplasmic protein that is highly
expressed in the developing mouse pancreas. However, the morphological and molecular events regulated by Sel1l
remain elusive.
Results: We have characterized the pancreatic phenotype of mice carrying a gene trap mutation in Sel1l. We show
that Sel1l expression in the developing pancreas coincides with differentiation of the endocrine and exocrine
lineages. Mice homozygous for the gene trap mutation die prenatally and display an impaired pancreatic epithelial
morphology and cell differentiation. The pancreatic epithelial cells of Sel1l mutant embryos are confined to the
progenitor cell state throughout the secondary transition. Pharmacological inhibition of Notch signaling partially
rescues the pancreatic phenotype of Sel1l mutant embryos.
Conclusions: Together, these data suggest that Sel1l is essential for the growth and differentiation of endoderm-
derived pancreatic epithelial cells during mouse embryonic development.
Background
The multiple cell types that make up the adult pancreas,
including endocrine, exocrine and ductal cells, derive
from a common pool of pancreatic progenitors. Pan-
creatic development in mice begins at embryonic day
9.5 (E9.5) with the formation of two epithelial buds on
the dorsal and ventral side of the primitive gut endo-
derm [1]. Epithelial cells within the pancreatic buds pro-
liferate rapidly and branch out during later embryonic
days to form a complex tubular network comprised of
undifferentiated multipotent progenitor cells [2,3]. Start-
ing at E13.5, the expanded pancreatic epithelial cells
undergo an asynchronized wave of differentiation to
give rise to all the differentiated cell types of the adult
pancreas, including acinar cells that produce hydrolytic
digestive enzymes and islet cells that secrete endocrine
hormones [4,5]. Pancreatic morphogenesis depends on a
complex and yet incompletely characterized network of
transcription factors. Significant efforts have been made
in the past few years to understand the role of several
important transcription factors, including Pdx1 [6,7],
Ptf1a [8,9], Sox9 [10,11]9, Ngn3 [12,13], NeuroD1
[14,15], Pax4 [16], Pax6 [17], Nkx2.2 [18], Nkx6.1 [19],
Arx [20], Isl1 [21] and Insm1 [22]. It is generally
accepted that these transcription factors coordinate pan-
creatic morphogenesis by functioning in concert to
restrict the developmental potentials of the pancreatic
progenitors in a spatial and stage-specific manner [23].
Several previous studies have underscored the impor-
tance of Notch-mediated signaling in regulating pancrea-
tic cell proliferation and cell fate decisions through
control of Ngn3 gene expression. During pancreatic
development, Ngn3 is transiently expressed in a subset of
the pancreatic epithelial cells. NGN3 deficiency comple-
tely abolishes formation of all the endocrine cell sub-
types, suggesting Ngn3 functions as a master switch for
the endocrine lineage in the pancreas. Mutations in
genes encoding Notch signaling pathway components,
such as DLL1 (ligand), RBP-Jk (the intracellular media-
tor), or HES-1 (the effector) causes expansion of Ngn3
expression in pancreatic cells and, as a result, accelerated
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any medium, provided the original work is properly cited.differentiation of endocrine cells at the expense of acinar
and ductal cells [13,24,25]. Conversely, over or persistent
expression of the Notch intracellular domain (NICD), a
constitutively active form of Notch receptors, or the
Notch effector gene Hes1 results in diminished expres-
sion of Ngn3 and attenuated differentiation of endocrine
cells [26-28]. These studies suggest that during pancrea-
tic development Notch signaling controls the endocrine
and exocrine cell fate decisions of pancreatic epithelial
cells by directly regulating Ngn3 expression. Recent stu-
dies have also indicated the importance of Notch signal-
ing in control of exocrine cell differentiation. Ectopic
expression of activated NOTCH-1 prevents or signifi-
cantly delays differentiation of acinar cells [26,27].
While the role of Notch signaling in control of pan-
creatic cell proliferation and cell fate decisions is clearly
recognized, the molecular mechanisms necessary for
proper control of Notch signaling during vertebrate pan-
creatic development are poorly understood. Genetic and
biochemical studies in invertebrates suggest that regula-
tion of Notch signaling occurs at various levels and
through multiple mechanisms [29-31]. These include
stochastic and/or developmental expression of the
Notch receptors and their ligands [32-34], selective
receptor-ligand interactions [35,36], intracellular protein
trafficking [37] and stability of NICD [38]. Suppressor
enhancer lin12 1 like (Sel1l) encodes a cytoplasmic pro-
tein that is highly conserved throughout the vertebrate
kingdom [39]. RNA in situ hybridization and immuno-
histological analysis revealed that Sel1l is highly
expressed in both the embryonic and adult pancreas
[40-42]. The human Sel1l gene is located in a chromo-
some region that is in close proximity to a type 1 dia-
betes high risk locus, IDDM-11 (insulin-dependent
diabetes mellitus locus 11), prompting the speculation
that mutations in Sel1l may be associated with the
pathogenesis of type 1 diabetes [43]. Sel-1, the C. elegans
ortholog of Sel1l, was first identified in a genetic screen
for mutations that suppress lin-12/Notch activity [44].
Subsequent biochemical studies demonstrated that Sel-1
negatively regulates lin-12/Notch activity by controlling
lin-12/Notch turn-over [45,46]. Based on these findings,
it has been suggested that Sel1l may also function as a
negative regulator for Notch signaling [47]. Recent bio-
chemical and molecular studies in vitro revealed that
Sel1l is also required for maintaining homeostasis of the
endoplasmic reticulum (ER). SEL1L nucleates an ER
membrane protein complex that is required for disloca-
tion of unfolded or misfolded proteins from the ER
lumen into the cytosol for degradation [48,49].
In an attempt to decipher the developmental and phy-
siological roles of Sel1l, we have generated and charac-
terized mice carrying a gene trap mutation in the Sel1l
gene. We report here that Sel1l expression during
pancreas development coincides with differentiation of
pancreatic epithelial cells into both the endocrine and
exocrine lineages. Homozygous Sel1l mutant embryos
exhibit an impaired pancreatic epithelial growth and
branching morphology. Pharmacological inhibition of
Notch signaling rescues the pancreatic phenotype of
Sel1l-deficient embryos. These data are consistent with
the notion that Sel1l functions as a negative regulator for
Notch signaling during pancreatic organogenesis [47].
Results
Sel1l expression during mouse pancreatic development
We generated mice carrying a gene-trap insertion in the
Sel1l gene. The gene trap cassette, located in intron 14,
contains a b-galactosidase-neomycin (bgeo) fusion
reporter gene. To determine the spatiotemporal expres-
sion pattern of Sel1l in the developing mouse pancreas,
we performed immunohistological analysis of pancreatic
sections from Sel1l
+/bgeo embryos using antibodies
against b-galactosidase (bgal) and several pancreatic pro-
teins, including SOX9 and PDX1 (progenitor markers),
insulin and glucagon (endocrine lineage markers) and
amylase (exocrine lineage marker). bgal expression was
first detected at E12.5 in a small number of cells located
within the core of SOX9-expressing pancreatic epithe-
lium (Fig. 1A-B). The bgal
+ cells at E12.5 express either
glucagon (Fig. 1C) or insulin (Fig. 1D), indicating that
they were early endocrine cells. bgal expression expands
significantly between E12.5 and E14.5. At E14.5, differ-
ential bgal expression was detected in the PDX1
+ cells
throughout the pancreatic epithelium (Fig. 1E). Epithe-
lial cells with markedly lower bgal expression corre-
spond to a subset of PDX1
+ cells that express SOX9
(Fig. 1F). At E15.5, high bgal expression was detected in
the core of the differentiating pancreas (Fig. 1G-H,
asterisks). These bgal
+ cells were positive either for glu-
cagon or insulin (arrows in Fig. 1I and 1J, respectively).
At birth, bgal expression was detected in both islet and
acinar cells (Fig. 1K-L, asterisk and arrow, respectively).
Taken together, these expression data indicate that Sel1l
is selectively expressed in the differentiating or differen-
tiated pancreatic epithelial cells.
SEL1L deficiency results in defective pancreatic epithelial
growth and branching morphogenesis
The gene trap in Sel1l contains a strong splicing accep-
tor signal that efficiently blocks splicing between exon
14 and 15, resulting in a truncated Sel1l transcript.
Homozygous gene trap mice (Sel1l
bge/bgeo) exhibit sys-
temic endoplasmic reticulum stress and die before E13.5
to E15.5 (Additional file 1). To determine if Sel1l is
required for pancreatic epithelial growth, we performed
morphometrical analysis of the developing pancreas of
viable Sel1l
bgeo/bgeo embryos. At E11.5, the dorsal and
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bgeo/bgeo embryos
appeared to be closely linked (Fig. 2B), as compared to
those in wild-type embryos (Fig. 2A). There was no sig-
nificant difference in the pancreatic epithelial size
between wild-type and Sel1l
bgeo/bgeo embryos (Fig. 2E).
At E13.5, the dorsal pancreatic bud of Sel1l
bgeo/bgeo
embryos (Fig. 2C) was clearly smaller than that of wild-
type embryos (Fig. 2F). In addition, while wild-type
pancreatic epithelium displayed a well-branched struc-
ture, mutant pancreatic epithelium appeared to be a
simple tube of epithelial cells. TUNEL assays revealed
no significant increase of apoptosis in the developing
pancreas of Sel1l mutant embryos (data not shown).
Immunostaining using anti-PCNA (a cell proliferation
indicator) antibody indicated that the pancreatic epithe-
lium of Sel1l mutant embryos had a significantly lower
Figure 1 Spatiotemporal expression of Sel1l during development of the mouse pancreas. Pancreatic sections from timed Sel1l
+/bgeo
embryos were co-immunostained with antibodies against bGal (red) and various pancreatic markers (green) as indicated on the left side of each
panel. (B and H) Magnified views of the boxed area in A and G, respectively. (A-D) bGal expression at E12.5. bGal expression begins in a small
number of cells within the core pancreatic epithelium at E12.5 (A). At this stage, there is no co-expression of bGal and SOX9 (B); however, bGal
is co-expressed with either glucagon (C) or insulin (D). (E-F) bGal expression at E14.5. bGal is differentially expressed in the PDX1
+ cells (E). While
high bGal signal was detected in the epithelial branches (arrows), no or very low Gal signal was detected in the core “duct-like” epithelium
(arrowhead). These core epithelial cells correspond to the subset of PDX
+ cells that express SOX9 (F). (G-J) bGal expression at E15.5. bGal
expression increases markedly in the core pancreatic epithelium (G and H, asterisks). bGal co-localizes with either glucagon (I, arrows) or insulin
(J, arrows). (K-L) bGal expression at postnatal day 1. bGal is expressed in both islet and acinar tissues (K, asterisk and arrow, respectively). bGal
co-localizes with PDX1 in the islet tissue (L). Scale bars: (A, G, I and J)5 0μm; (B-F, K-L) 100 μm.
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epithelium (Fig. 2G). Together, these results indicate
that Sel1l, while dispensable for pancreatic epithelial
induction, is essential for the subsequent growth and
branching morphogenesis of the pancreatic epithelial
cells.
SEL1L deficiency inhibits differentiation of acinar cells and
significantly attenuates differentiation of endocrine cells
We next investigated the role of Sel1l in pancreatic
epithelial cell differentiation. Since the first wave of cell
differentiation occurs before E12.5 and the cells gener-
ated are mostly a-cells, we analyzed glucagon expression
Figure 2 Impaired pancreatic epithelial growth and branching morphogenesis in Sel1l
bgeo/bgeo embryos.( A-D) Immunohistological
analysis of the developing pancreas of wild-type and Sel1l
bgeo/bgeo embryos at E11.5 and E13.5; the genotypes of the pancreatic sections are
indicated as +/+ and -/-, respectively. The following antibodies were used: Pdx1 (A-D, green) and insulin (C-D, red). (A-B) The dorsal and ventral
pancreatic buds in Sel1l
bgeo/bgeo embryos are fused together. (C-D) The dorsal pancreatic bud of Sel1l
bgeo/bgeo embryos exhibits a markedly
reduced epithelial size and an impaired branching morphology. (E-F) Statistical analyses of estimated pancreatic epithelial sizes of wild-type and
Sel1l
bgeo/bgeo embryos at E11.5 (E) and E13.5 (F). Data were from three sets of wild-type and Sel1l
bgeo/bgeo embryos. No significant difference in
the epithelial sizes of wild-type and Sel1l-deficient pancreas at E11.5 was detected (E). At E13.5, the pancreatic epithelium of Sel1l-deficient
embryos was significantly smaller (F). Scale bar: 100 μm.
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bgeo/bgeo embryos. As shown in Fig. 3A-B
and 3G, comparable numbers of glucagon
+ cells were
observed in wild-type and Sel1l
bgeo/bgeo embryos. Sel1l is
thus unlikely to be required for the generation of early
endocrine cells during the first transition (E9.5 to
E12.5).
While the majority of Sel1l
bgeo/bgeo embryos (95%) die
before the initiation of the major wave of cell differen-
tiation in the developing pancreas (E13.5), about 5% of
these embryos are viable at E15.5. To determine if Sel1l
is required for differentiation of pancreatic epithelial
cells during the secondary transition (E13.5 to E15.5),
we analyzed the expression of three pancreatic lineage
markers: insulin (b-cells), glucagon (a-cells) and amylase
(acinar cells) in these embryos. Significant numbers of
glucagon
+ and insulin
+ cells were detected in wild-type
embryos at E15.5 (Fig. 3C and 3E). In contrast, the
numbers of glucagon
+ and insulin
+ cells were signifi-
cantly reduced in Sel1l
bgeo/bgeo embryos (Fig. 3D and 3F,
3 Ha n d3 I ) .A b u n d a n ta m y l a s e
+ cells are present in
wild-type embryos at E15.5 (Fig. 4E). In contrast, no
amylase
+ cells are detectable in Sel1l
bgeo/bgeo embryos
(Fig. 4F). Disruption of Sel1l function thus results in an
impaired differentiation of both acinar and islet cells.
SEL1L-deficient pancreatic epithelium exhibits inhibited
growth and differentiation ex vivo
To ensure that the growth and differentiation defects
observed in Sel1l
bgeo/bgeo embryos were not due to the
effect of global embryonic growth retardation of these
embryos, we studied the pancreatic phenotype of Sel1l
bgeo/
bgeo embryos using an organ culture system. The dorsal
pancreatic bud of wild-type and Sel1l
bgeo/bgeo embryos
were isolated at E11.5 and cultured for 8 days. The cul-
tured pancreatic explants were then analyzed by immuno-
fluorescence using antibodies against PDX1 and insulin. In
general, Sel1l-deficient pancreatic epithelium grows poorly
(Suppl. Fig. 2B and 2D) with about half of the cultured
mutant epithelia failing to form branched epithelial struc-
tures. This is in sharp contrast to the growth behavior of
wild-type pancreatic epithelia, which form a branched
epithelial structure (Additional file 2). The number of
insulin
+ cells was significantly decreased in Sel1l-deficient
pancreatic explants (Fig. 4B), as compared to that in wild-
type control explants (Fig. 4A). Amylase
+ cells were
detected in cultured Sel1l-deficient explants (Fig. 4D),
although the number of amylase
+ cells was significantly
lower compared to that in wild-type control explants (Fig.
4C). Thus, the pancreatic epithelium of Sel1l
bgeo/bgeo
embryos displays impaired growth, branching morphogen-
esis and lineage differentiation ex vivo. These findings con-
firm that the pancreatic defects observed in Sel1l-deficient
embryos at E15.5 are not due to the global growth
retardation.
Pancreatic progenitor cells in SEL1L-deficient embryos at
E15.5 are confined to a pluripotent progenitor state
To gain insight into the molecular basis underlying the
pancreatic defects in Sel1l
bgeo/bgeo embryos, we first ana-
lyzed the expression of several transcription factors
important for pancreatic epithelial growth and lineage
formation. Immunostaining was carried out to assess the
expression of Sox9, Pdx1 and Ptf1a in E15.5 Sel1l
bgeo/bgeo
embryos. PDX1 expression was uniformly detected in
the pancreatic epithelial cells of Sel1l
bgeo/bgeo embryos
(Fig. 5B). This is in sharp contrast to wild-type embryos
where PDX1 expression was differentially expressed in
the pancreatic epithelial cells, with high expression in a
subset of the core epithelial cells and low expression in
the peripheral epithelial cells (Fig. 5A, white arrow and
red arrowheads, respectively). No PTF1a expression was
detected in the pancreatic epithelium of Sel1l
bgeo/bgeo
embryos (Fig. 5B), whereas clear co-expression of PTF1a
and PDX1 was detected in the proacini in the periphery
of the pancreatic epithelial buds (Fig. 5A, white arrows).
SOX9 was detected in approximately 20% of the PDX1
+
cells in wild-type embryos (Fig. 5C, red arrows). In con-
trast, SOX9 expression was observed in more than 70%
of the PDX1
+ cells in Sel1l
bgeo/bgeo embryos (Fig. 5D,
asterisk). These findings are consistent with the notion
that the pancreatic epithelial cells in Sel1l
bgeo/bgeo
embryos at E15.5 are restricted the pancreatic progeni-
tor state.
Pharmacological inhibition of Notch signaling rescues
endocrine lineage formation in Sel1l
bgeo/bgeo embryos
Sel1l was thought to be a negative regulator for Notch sig-
naling [47]. Indeed, the pancreatic phenotype in Sel1l
bgeo/
bgeo embryos shows remarkable similarity to that of mouse
or zebrafish embryos over-expressing Notch intracellular
domain, the constitutively active form of Notch receptors
[26,28,50]. We speculated that the impaired pancreatic
epithelial growth and differentiation in Sel1l-deficient
embryos may be due to an increased Notch signaling
activity. To test this possibility, we used the g-secretase
inhibitor, DAPT (Difluorophenacetyl-al-alanyl-S-phenyl-
glycine-t-butyl ester), to suppress Notch signaling in pan-
creatic explants culture. The dorsal pancreatic bud of
wild-type and Sel1l
bgeo/bgeo embryos was isolated at E11.5
a n dc u l t u r e df o r8d a y si nt h ea b s e n c eo rp r e s e n c eo f
DAPT. At a concentration of 10 μM, DAPT did not exhi-
bit detectable effects on the growth, branching morphol-
ogy and endocrine cell differentiation of wild-type
pancreatic epithelium (Fig. 6A-B and 6E). At the same
concentration, however, DAPT caused a significant expan-
sion of the SEL1L-deficient pancreatic epithelium (Fig.
6C-D). Importantly, DAPT treatment resulted in a marked
increase in the number of insulin
+ cells (Fig. 6D and 6F).
These observations indicate that pharmacological
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bgeo/bgeo embryos.( A-F) Immunohistological analysis of the
developing pancreas of Sel1l
+/+ and Sel1l
bgeo/bgeo embryos at E11.5 (A-B) and E15.5 (C-F); the genotypes of the pancreatic sections are indicated
as “+/+” and “-/-”, respectively. The following antibodies were used: Pdx1 (A-D, green), glucagon (A-D, red), insulin (E-F, red) and amylase (E-F,
green). (A-B) At E11.5, Glu
+ cells were detected in the pancreatic epithelium of wild-type and Sel1l
bgeo/bgeo embryos in equal numbers. (C-D)A t
E15.5, the number of glucagon
+ cells was reduced in Sel1l
bgeo/bgeo embryos as compared to wild-type control. (E-F) No amylase
+ cells were
detected and the number of insulin
+ cells was significantly reduced in Sel1l
bgeo/bgeo embryos. (G-I) Statistical analyses of the numbers of
glucagon
+ and insulin
+ cells in wild-type and Sel1l
bgeo/bgeo embryos. Data were from three wild-type and three Sel1l
bgeo/bgeo embryos. At E11.5,
no significant difference in the number of glucagon
+ cells in wild-type and Sel1l
bgeo/bgeo embryos was detected (G). The number of glucagon
+
and insulin
+ cells was markedly lower in Sel1l
bgeo/bgeo embryos than in wild-type control embryos (H and I, respectively). Scale bar: 100 μm.
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pancreatic epithelial growth and endocrine differentiation
defects of Sel1l
bgeo/bgeo embryos.
Discussion
The genetic determinants underlying vertebrate pancrea-
tic development are not completely understood. In the
present study, we report that Sel1l expression in the
developing mouse pancreas coincides with differentia-
tion of the endocrine and exocrine lineages during the
second transition. Embryos homozygous for a gene trap
insertion in Sel1l display impaired pancreatic epithelial
growth and differentiation. Pharmacological inhibition
of Notch signaling partially rescues the pancreatic
phenotype of SEL1L-deficient embryos. Together, these
data provide evidence that Sel1l is required for growth
and differentiation of the mammalian pancreatic epithe-
lial cells. The underlying mechanism may be that Sel1l
functions as a negative regulator for the Notch signaling
pathway by facilitating degradation of the Notch intra-
cellular domain.
Donoviel et. al. previously reported that the mouse
Sel1l gene is highly transcribed in the acini of the devel-
oping pancreas at E14.5 and E17.5 [41]. We show, by
immunohistological analysis of the b-galactosidase
reporter in Sel1l,t h a tSel1l is also highly expressed in
early glucagon
+ and insulin
+ cells (Fig. 1C and 1D,
respectively) generated during the first transition period
Figure 4 Sel1l-deficient pancreatic epithelium exhibits impaired growth, branching morphology and differentiation ex vivo.D o r s a l
pancreatic buds of wild-type and Sel1l
bgeo/bgeo embryos were isolated at E11.5 and cultured as described in Materials and Methods. The
genotypes of the pancreatic explants are indicated as “+/+” and “-/-”, respectively. Cultured pancreatic explants were immunostained using the
indicated antibodies. Sel1l-deficient pancreatic epithelium grows poorly and displays impaired branching morphology (B and D), as compared to
wild-type control explants (A and C). The number of insulin+ cells in mutant pancreatic epithelia were markedly reduced (B, arrows), as
compared to the wild-type controls (A, arrows). Amylase expression was detected in Sel1l-deficient pancreatic epithelium (D, arrows), but the
expression is significantly lower than that in wild-type epithelium (C, arrows). Scale bar: 100 μm.
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Sel1l mRNA expression pattern reported by Donoviel
et. al., we reveal that at E14.5 Sel1l is broadly expressed
in the PDX1
+ pancreatic epithelia (Fig. 1E). Interest-
ingly, significantly lower Sel1l expression is observed in
the undifferentiated pancreatic epithelial cells (Fig. 1F)
that express SOX9 [10,11]. Our findings therefore indi-
cate that Sel1l expression is enhanced in the committed
pancreatic epithelial cells or differentiated endocrine
and exocrine cells.
The selective expression of Sel1l in differentiating or
differentiated pancreatic epithelial cells is highly sugges-
tive of a role for Sel1l in promoting lineage differentiation
during the secondary transition. To define the role of
Sel1l in pancreatic development, we characterized the
pancreatic phenotype of embryos homozygous for a gene
trap insertion in Sel1l. We show that wild-type and Sel1l-
deficient embryos have a comparable pancreatic epithelial
size at E11.5 (Fig. 2A-B and 2E), suggesting that Sel1l
function is dispensable for the induction and early
growth of pancreatic epithelial cells. At E13.5, however,
Sel1l-deficient pancreatic epithelia are significantly smal-
ler and display an impaired branching morphology (Fig.
2C-D and 2F). Importantly, Sel1l-deficient pancreatic
epithelia at E15.5 completely lack amylase
+ cells (Fig. 3F)
and have significantly reduced numbers of glucagon
+ and
insulin
+ cells (Fig. 3D and 3F, respectively). Also, by ana-
lyzing the phenotype of cultured Sel1l-deficient dorsal
pancreatic epithelia, we confirmed that the pancreatic
defects in Sel1l-deficient embryos are not due to the
effect of global growth retardation of the Sel1l-deficient
embryos (Fig. 4A-D). Together, these data strongly sug-
gest that Sel1l plays an important role in mouse pancrea-
tic organogenesis by facilitating differentiation of the
endocrine and exocrine lineages of the pancreas.
The C. elegans ortholog of the mammalian Sel1l gene,
Sel-1, was originally identified by genetic screening as a
negative regulator for lin-12/Notch signaling [44,53]. Bio-
chemical studies have shown that Sel-1 regulates lin-12/
Notch receptor turnover [45,46]. Whether or not Sel1l has
similar functions in the mammalian system remains
unclear [54]. In this study, we provide two lines of
Figure 5 Sel1l-deficient pancreatic epithelial cells fail to commit to lineage precursors during the secondary transition.( A-D)
Immunohistological analysis of the developing dorsal pancreas of wild-type and Sel1l
bgeo/bgeo embryos at E15, using the indicated antibodies.
The genotypes of the pancreatic sections are indicated as “+/+” and “-/-”, respectively. (A-B) PTF1a is expressed in the periphery of wild-type
pancreatic epithelium marking the commitment of pancreatic epithelial cells into the exocrine lineage (A, white arrows); PTF1a expression is
absent in the mutant pancreas (B). Up-regulation of PDX1 expression in a subset of epithelial cells in the core of wild-type pancreatic epithelium
marks the commitment of pancreatic epithelial cells into the endocrine lineage (A, red arrows); whereas PDX1 is uniformly expressed in mutant
pancreatic epithelial cells (B). (C-D) SOX9 is expressed in a small population of epithelial cells in wild-type pancreatic epithelium (C, red arrows);
in contrast, SOX9 mostly co-localizes with PDX1 in mutant pancreatic epithelium (D, asterisks). Scale bar: 100 μm.
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regulator for Notch signaling, at least in the developing
mouse pancreas. First, the observed pancreatic phenotype
in Sel1l mutant embryos show remarkable similarity to the
pancreatic phenotype of transgenic vertebrate embryos
over-expressing the Notch intracellular domain, the con-
stitutively active form of Notch [26,28,50]. Second, we
show that treatment of cultured Sel1l-deficient pancreatic
epithelium with DAPT, a potent Notch signaling inhibitor,
partially rescues the growth and differentiation defects of
Sel1l-deficient pancreatic epithelium (Fig. 6D and 6F).
How does SEL1L negatively control Notch signaling in
the developing mammalian pancreas is the focus of our
current investigation. Genetic and biochemical evidences
from other organisms such as Drsophila and C. elegans
suggest that Notch signaling is regulated at multiple
levels and through multiple mechanisms, including sto-
chastical gene expression [34], selective ligand-receptor
interactions [35], intracellular trafficking [37], and stabi-
lity of NICD, the active form of Notch receptors [30].
Given the previous finding that mammalian NICD are
ubiquitinated and degraded through both the proteaso-
mal and lysosomal systems [55,56], it is conceivable that
Sel1l may be directly or indirectly involved in control of
NICD degradation. In this regard, it is noteworthy to
mention that recent biochemical data from our labora-
tory indicate that NICD has significantly higher protein
stability in Sel1l-deficient MEF cells (data not shown).
Figure 6 DAPT treatment rescues the pancreatic phenotype of Sel1l
bgeo/bgeo embryos. The dorsal pancreatic bud of wild-type (+/+) and
Sel1l mutant (-/-) embryos was isolated at E11.5 and cultured for 8 days in the presence of 0.1% DMSO (control) and 10 μM of DAPT. (A-D)
Immunohistological analysis of DAPT-treated and non-treated pancreatic buds with the indicated antibodies. (E-F) Quantification of insulin
+ cells
in DMSO and DAPT-treated pancreatic explants. DAPT did not significantly change the number of insulin
+ cells in wild-type pancreatic buds (A-B
and E), however, it induced a marked increase of insulin
+ cells in Sel1l mutant pancreatic buds (C-D and F). Scale bar: 100 μm.
Li et al. BMC Developmental Biology 2010, 10:19
http://www.biomedcentral.com/1471-213X/10/19
Page 9 of 13Further proof of this hypothesis will require a detailed
biochemical analysis of SEL1L and Notch interactions.
Biochemical evidences from other laboratories have
also underscored the importance of Sel1l in maintaining
ER homeostasis. SEL1L interacts with the E3 ubiquitin
ligase HRD1 to facilitate the dislocation of unfolded or
misfolded proteins from the ER lumen into the cytosol
for degradation [48,49,57-60]. Consistent with this, we
have recently shown that homozygous Sel1l mutant
mice develop systemic ER stress. The impact of ER
stress on pancreatic epithelial proliferation and differen-
tiation remains undefined from the current study. How-
ever, several hypothetical roles of ER stress in pancreatic
organ development and growth can be proposed. First,
ER stress affects global gene expression. Upon ER stress,
translation is generally down to reduce production of
ER client proteins. Concomitantly, transcription of genes
encoding ER chaperones and ER-associated degradation
(ERAD) machinery is increased. Second, ER stress
blocks or reduces protein secretion by mammalian cells.
This will directly affect cell signaling and cell functions.
Finally, prolonged ER stress activates the signaling path-
ways leading to apoptosis.
Conclusions
We report that during mouse pancreatic development,
Sel1l is preferentially expressed in the differentiating or
differentiated pancreatic epithelial cells. Disruption of
Sel1l function results in impaired endocrine lineage for-
mation and delayed exocrine lineage differentiation.
Pharmacological suppression of Notch signaling in cul-
tured pancreatic explants partially rescues the endocrine
cell differentiation defect. Our data suggest that Sel1l
may regulate pancreatic epithelial growth and differen-
tiation by suppressing Notch-mediated signaling.
Methods
Sel1l gene trap mice
T h ec h i m e r i cf o u n d e rm o u s eu s e dt og e n e r a t eS el1l
gene trap mice was generated by microinjection of a
commercially available mouse embryonic stem (ES) cell
clone, CA0017, into C57/BL6 blastocysts. This ES cell
clone contains a gene trap insertion in the 14
th intron of
the Sel1l gene. All mice or mouse embryos were geno-
typed by PCR analysis of tail or toe genomic DNA using
the following PCR primers:
F-Sel1l: 5’-TGGGACAGAGCGGGCTTGGAAT-3’;
R-Sel1l: 5’-CACCAGGAGTCAAAGGCATCACTG-3’;
R-bGeo: 5’ATTCAGGCTGCGCAACTGTTGGG-3’.
All animal experiments were performed in accordance
with the Cornell Animal Care and Use Guidelines.
Histology and immunohistochemistry
Embryos or pancreatic rudiments were fixed in 4% par-
aformaldehyde (PFA) in PBS at 4°C for 12 hours or
longer. PFA-fixed specimens were equilibrated in 30%
sucrose in PBS at 4°C and embedded in O.C.T. Sections
w e r ec u ta t1 0μm and immunostained essentially as
described [61,62]. Briefly, tissue sections were permeabi-
lized with 0.2% Triton X-100 in PBS for 20 min, washed
3 times in 0.1% Triton X-100 in PBS and 3 times in
PBS. The permeabilized sections were pre-incubated
with 5% normal donkey serum and 1% BSA in PBS at
room temperature for at least 1 hour, followed by incu-
bation in the same solution with primary antibodies at
4°C overnight. The antibody-bound sections were then
washed three times in 0.1% Triton X-100 in PBS, 3
times in PBS and then incubated with secondary antibo-
dies for 1-3 hrs at room temperature. Primary antibodies
were diluted in 1% BSA in PBS as follows: rabbit anti-b-
Galactosidase (Immunology Consultants Laboratory),
1:500; guinea pig anti-Pdx-1 (Abcam), 1:1000; goat anti-
Pdx1 (Abcam), 1:1000; guinea pig anti-insulin (Linco),
1:1000; rabbit anti-glucagon (Covance), 1:500; goat anti-
glucagon (AbD Serotec), 1:200; rabbit anti-Sox9 (gift
from Dr. Michael Wegner), 1:1000; rabbit anti-Ptf1a
(gift from Dr. Helena Edlund), 1:1000); and rabbit anti-
amylase (Sigma), 1:500. Secondary antibodies were
diluted in 1% BSA in PBS as follows: donkey anti-rabbit
IgG conjugated to Cy3 (Jackson Immuno Research),
1:1000; donkey anti-guinea pig IgG conjugated to Cy2
(Jackson Immuno Research), 1:500. Fluorescence images
were acquired using an Axiovert 40 microscope (Zeiss)
equipped with an AxioCam camera.
Pancreatic morphometry and cell counting
Quantitative morphometry of the developing pancreas
and cell counting were performed essentially as described
[11]. Briefly, pancreata of age-matched wild-type and
Sel1l
bgeo/bgeo embryos were sectioned through and every
fifth section was immunostained with anti-PDX1 or co-
immunostained with anti-PDX1 and anti-Glucagon.
Quantification of pancreatic epithelium area (PDX1
+
area) was performed using AxioVision Imaging analysis
software (version 4.6.3). The data were presented as
averages ± SEM (μm
2) of three independent pancreata.
Statistical analysis was performed using the Student’s
two-sample t test and significance is regarded as p ≤ 0.05.
Pancreatic organ culture and DAPT treatment
Sel1l
+/bgeo mice were intercrossed to generate embryos
of defined genotypes: wild-type (Sel1l
+/+), heterozygous
(Sel1l
+/bgeo)a n dh o m o z y g o u s( Sel1l
bgeo/bgeo). The day of
the vaginal plug was taken as embryonic (E) day 0.5.
Pancreatic bud dissection and culture were performed
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decapitated and the dorsal pancreatic rudiment together
with surrounding mesenchymal tissue was removed in
PBS. The dissected pancreatic buds were rinsed once in
culture medium, transferred to a fibronectin-coated 8-
well LabTek chamber slide with the epithelial side
touching the bottom of the slide and cultured for 72
hours in basal medium with Earle’s salts (Gibco 21010-
046), 1 × glutamine, 10% FBS and antibiotics. The cul-
tured pancreatic rudiments were fixed individually for
30 minutes in 4% paraformaldehyde in PBS for immu-
nohistological analysis. DAPT treatment of cultured
pancreatic explants was performed essentially as
described [64]. DAPT stock solution was prepared at a
concentration of 10 mM in DMSO and was aliquoted
into single-usage aliquots. For Notch inhibition experi-
ments, pancreatic buds were cultured in complete med-
ium containing 10 μM of DAPT. Control pancreatic
buds were cultured in complete medium containing
0.1% DMSO. The DMSO or DAPT-treated pancreatic
buds were briefly fixed and analyzed by immunostaining.
Additional file 1: Characterization of the gene trap allele in Sel1l.( A)
Schematic representation of the wild-type (Sel1l
+) and gene trap
(Sel1l
bgeo) allele in Sel1l. Solid black rectangles represent exons; the open
box in the Sel1l
- allele represents the gene trap insertion. Splicing events
are indicated by dashed lines. (B) PCR analysis of genomic DNAs from
wild-type (WT), heterozygous (HT) and mutant (MU) mice using the
indicated Sel1l and bgeo-specific primers (arrows). The data confirm the
presence of a gene trap insertion in intron 14. (C) RT-PCR analysis of
RNAs from E12.5 WT, HT and MU embryos using the indicated Sel1l and
bgeo-specific primers (arrows). The data indicate that the gene trap allele
in Sel1l completely blocks RNA splicing between exon 14 and 15,
resulting in a truncated Sel1l transcript fused in frame with bgeo
transcript. (D) Schematic representation of the full-length (FL) (top) and
deletion mutant (DM) SEL1L peptides generated from the wild-type and
gene trap Sel1l alleles. Key protein domains are shown in colored boxes.
Numbers represent amino acid positions. The gene trap allele in Sel1l
generates a fusion protein containing the N-terminal 465 amino acids of
SEL1L and bgeo. The mutant peptide lacks the Hrd3-like motif, the
transmembrane domain, the proline-rich domain and 4 SEL1L-like
repeats.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-
19-S1.PDF]
Additional file 2: Sel1l-deficient pancreatic epithelium exhibits
impaired growth, branching morphology and differentiation ex
vivo. The dorsal pancreatic bud of wild-type (+/+) and Sel1l
bgeo/bgeo (-/-)
embryos were isolated at E11.5 and cultured as described in Materials
and Methods. Cultured pancreatic explants were immunostained with
the indicated antibodies. Sel1l-deficient pancreatic epithelium grows
poorly and displays impaired branching morphology (B and D), as
compared to wild-type control explants (A and C). Scale bar: 100 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-
19-S2.TIFF]
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